Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Other flags are autoimmune diseases, infections, recent surgery, blood thinners, and kidney or liver impairment
It dramatically slows down the metabolic processes of any potential bacteria that may have been introduced, making it much harder for them to multiply
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
There should be no side effects, no pain, no oozing, and no problem with the injection site
US$ 22.92
US$ 23.68
US$ 27.16
US$ 22.41
US$ 20.61
US$ 21.37
